Alerts will be sent to your verified email
Verify EmailTATVA
Tatva Chintan Pharma
|
Ultramar & Pigments
|
Paushak
|
|
---|---|---|---|
Operational Metrics
|
|||
Chemical Sector
|
|||
Capacity Utilization - Chemicals - Reactor
|
69.76 % | n/a | n/a |
Pharmaceutical Sector
|
|||
Total reactor capacity
|
500.0 kL | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
19.37 % | 8.48 % | 14.0 % |
5yr average Equity Multiplier
|
1.6 | 1.32 | 1.19 |
5yr Average Asset Turnover Ratio
|
0.74 | 0.51 | 0.46 |
5yr Avg Net Profit Margin
|
14.46 % | 12.7 % | 25.72 % |
Price to Book
|
2.9 | 1.51 | 2.85 |
P/E
|
375.3 | 19.58 | 26.9 |
5yr Avg Cash Conversion Cycle
|
136.22 Days | 32.34 Days | 3.28 Days |
Inventory Days
|
108.35 Days | 47.96 Days | 39.83 Days |
Days Receivable
|
71.34 Days | 36.47 Days | 91.28 Days |
Days Payable
|
79.58 Days | 58.83 Days | 124.62 Days |
5yr Average Interest Coverage Ratio
|
12.28 | 22.68 | 632.64 |
5yr Avg ROCE
|
21.27 % | 9.8 % | 16.52 % |
5yr Avg Operating Profit Margin
|
19.99 % | 18.77 % | 33.92 % |
5 yr average Debt to Equity
|
0.38 | 0.08 | 0.0 |
5yr CAGR Net Profit
|
-4.29 % | 6.11 % | 9.26 % |
5yr Average Return on Assets
|
11.17 % | 6.38 % | 11.77 % |
Shareholdings
|
|||
Promoter Holding
|
72.02 % | 40.61 % | 67.13 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-7.15 % | -3.46 % | 0.16 % |
Change in Mutual Fund Holding (3 Yrs)
|
-2.2 % | 0.0 | 0.0 |
Tatva Chintan Pharma
|
Ultramar & Pigments
|
Paushak
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|